Cargando…
S4.1d In vitro activity of eight antifungals against 3343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive mycosis and antifungals
S4.1 TREATMENT OF RARE MOLD INFECTIONS IN 2021: THE ROLE OF NEW AND OLD ANTIFUNGALS, SEPTEMBER 22, 2022, 10:30 AM - 12:00 PM: BACKGROUND & OBJECTIVES: The NRCMA oversees the surveillance of invasive fungal diseases in France. As part of our expertise, we perform antifungal susceptibility testi...
Autores principales: | Garcia-Hermoso, Dea, Lanternier, Fanny, Dromer, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515953/ http://dx.doi.org/10.1093/mmy/myac072.S4.1d |
Ejemplares similares
-
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
por: Georgacopoulos, Ourania, et al.
Publicado: (2021) -
P306 Scedosporium spp. and Lomentospora prolificans, fungal agents with unexpected vascular tropism
por: Vignals, Carole, et al.
Publicado: (2022) -
P253 Features of Cryptococcosis in human immunodeficiency virus-negative patients, France 1985-2020
por: Paccoud, Olivier, et al.
Publicado: (2022) -
P088 Molecular identification and antifungal susceptibility of pathogenic yeasts from the China Antifungal Resistance Surveillance Trial (CARST-fungi) Study
por: Wang, Qiqi, et al.
Publicado: (2022) -
In vitro antifungal effect of a plant-based product, CIN-102, on antifungal resistant filamentous fungi and their biofilms
por: D'agostino, Maurine, et al.
Publicado: (2021)